Realbotix (XBOT.F) Emerging Growth Virtual Conference 78 summary
Event summary combining transcript, slides, and related documents.
Emerging Growth Virtual Conference 78 summary
30 Jun, 2026Product innovation and technology
Showcased AI-powered humanoid robots at CES, receiving significant media attention and public interest.
Robots feature modular, patented design allowing quick face and AI swaps, and a new vision system enabling eye contact and object recognition.
Use cases include healthcare, military, marketing, retail, and elder care, with custom AI tailored for social interaction.
Synthetic skin technology is patented, offering high realism and durability, with advanced facial expressions.
Robots currently move on programmable wheeled bases; walking capability will be integrated when industry standards mature.
Market demand, partnerships, and business development
Post-CES, received increased inquiries from military, pharmaceutical, entertainment, and religious sectors.
Actively exploring partnerships, especially with technology and branding companies, but no new formal partners yet.
All robots are made to order, with busts priced around $10,000 and full-bodied models taking 4–6 months to deliver.
Considering third-party retail showrooms, with potential locations in major cities like New York.
Planning to scale production from 15–20 to several hundred robots annually by building a dedicated assembly facility.
Financials, corporate status, and strategic outlook
Financial statements for the year ending September 2024 will be released January 28, with Q1 results to follow.
Canadian listing is in good standing; exploring a Nasdaq listing to enhance liquidity and valuation.
No current stock buyback due to high share price, but capital is allocated for future buybacks if valuation drops.
Market cap is approximately $80 million.
Still holds crypto assets and a 15% stake in StoryFire, but focus is shifting to robotics and AI.
Latest events from Realbotix
- Q2-2026 revenue fell as focus shifted to AI robotics, but one-time gains drove profit and Nasdaq progress.XBOT.F
Q2 202629 May 2026 - Reverse takeover to NASDAQ, $125M valuation, and lifelike AI robots drive growth and visibility.XBOT.F
Investor presentation11 Mar 2026 - Debt-free, scaling robotics and AI, with strong cash and a major Nasdaq deal pending.XBOT.F
Q1 202610 Mar 2026 - Revenue up 121%, gross margin up, net loss narrowed, and company is now debt-free.XBOT.F
Q4 20259 Mar 2026 - Reverse takeover secures Nasdaq listing, majority ownership, and growth capital with no dilution.XBOT.F
M&A announcement13 Feb 2026 - Net income hit $3.4M as assets and revenue soared, with AI robot growth accelerating.XBOT.F
Q3 202423 Jan 2026 - AI-enabled humanoid robots for companionship drive growth in entertainment and healthcare.XBOT.F
2024 Sidoti Virtual Micro-Cap Conference14 Jan 2026 - AI-powered humanoid robots target social needs, with 2025 focused on scaling corporate sales.XBOT.F
Emerging Growth Conference 7711 Jan 2026 - FY-2024 revenue up 378% to $1.3M, with major CES-driven media and product momentum.XBOT.F
Q4 20249 Jan 2026